NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

GSP Crop Science Makes Moderate Debut in Indian Stock Market

Key Figures:

  • ₹320: IPO price of GSP Crop Science shares
  • ₹332.3: Opening price on the Bombay Stock Exchange (BSE)
  • ₹328: Opening price on the National Stock Exchange (NSE)

GSP Crop Science made its debut in the Indian stock market on Tuesday, March 24, with a moderate listing performance. The company's shares listed at a 4% premium over the initial public offering (IPO) price of ₹320.

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

As a result, IPO allottees gained 4% over the GSP Crop Science IPO listing, with the stock opening at ₹332.3 on the BSE and ₹328 on the NSE. This development marks the beginning of the company's journey in the Indian stock market, and investors will be closely watching its future performance.

Investor Takeaway

GSP Crop Science's IPO listing price was 4% above its initial public offering price.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.